We are led to question whether the recommended social distancing measures to prevent SARS-CoV-2 transmission could increase the number of other serious instabilities. The breaking of the contagion pathways reduces the sharing of microorganisms between people, thus favoring dysbiosis, which,… Read More ›
Testosterone eliminated MS symptoms – Animal model By accident researchers discovered that a guardian molecule cytokine IL-33 that was produced due to testosterone eliminated MS symptoms in mice. Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proceedings of the National Academy… Read More ›
Multiple Sclerosis and Vitamin D recommendations We review the recent research looking into the effects of daily high doses of vitamin D3 (10,400 IU ) in people with multiple sclerosis. This research was published in the Dec. 30, 2015, online… Read More ›
Public Release: 19-Feb-2015 American Academy of Neurology WASHINGTON, DC – Women with multiple sclerosis (MS) may have lower levels of important antioxidant and anti-inflammatory nutrients, such as folate from food and vitamin E, than healthy people, according to a new… Read More ›
BMJ-British Medical Journal A common gut microbe might curb the risk of developing multiple sclerosis–at least in women–suggests the largest study of its kind published online in the Journal of Neurology Neurosurgery & Psychiatry. If confirmed in other studies, this… Read More ›
19 NOV 2012 Risk of MS highest in April and lowest in October, large analysis shows The risk of developing multiple sclerosis (MS) is highest in the month of April, and lowest in October, indicates an analysis of the available… Read More ›
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases JAMA Neurol. Published online October 20, 2014. doi:10.1001/jamaneurol.2014.2633 Importance Because vaccinations are common, even a small increased risk of multiple sclerosis (MS) or other acquired central… Read More ›
In September 2013 we reported on the trial ( Journal of Neuroimmunology 263 (2013) 64–74 ) involving the 100% remission rate in rodents of MS with a single injection of Calicitriol followed by oral vitamin D3. The possible protocol for future human… Read More ›
10 AUG 2012 STANFORD, Calif. — A molecule widely assailed as the chief culprit in Alzheimer’s disease unexpectedly reverses paralysis and inflammation in several distinct animal models of a different disorder — multiple sclerosis, Stanford University School of Medicine researchers… Read More ›
“Our findings provide support for the idea that a damaged intestinal barrier can prevent the body ending an autoimmune reaction in the normal manner, leading to a chronic disease such as MS”, said Dr Lavasani.” PUBLIC RELEASE DATE: 4-Sep-2014 Researchers… Read More ›
Public release date: 18-Oct-2011 Circadian disruption and sleep restriction contributing factors Researchers from Sweden have uncovered an association between shift work and increased risk of multiple sclerosis (MS). Those who engage in off-hour employment before the age of 20 may… Read More ›
Public release date: 29-Sep-2011 UCI study shows promise of metabolic therapy for autoimmune diseases A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study. UCI’s Dr. Michael Demetriou, Ani Grigorian and… Read More ›
Public release date: 31-Jan-2011 New research published in the Journal of Leukocyte Biology suggests that histamine plays an important role as an immune modulator, which could be a significant finding for multiple sclerosis research If you think histamines are your… Read More ›
Topics: Forgotten Breakthroughs – a team of University of Wisconsin-Madison biochemists has discovered a promising vitamin D-based treatment that can halt — and even reverse — the course of the disease in a mouse model of MS. – First, Hayes’… Read More ›
Public release date: 10-Oct-2010 A deficiency in one of the immune system’s enzymes affects the severity of autoimmune diseases such as MS, and explains why the course of these diseases can vary so much. New findings give an insight into… Read More ›
DECEMBER 30th 2015 (VIDEO) SEPTEMBER 29TH 2014 (VIDEO) FEBRUARY 14TH 2014 (VIDEO) HRR * Will be re-doing this segment with proper audio, in a few days Topics: Forgotten Breakthroughs – a team of University of Wisconsin-Madison biochemists has discovered a… Read More ›
Public release date: 19-Jul-2010 – To find out, Mazmanian and his colleagues tried to induce MS in animals that were completely devoid of the microbes that normally inhabit the digestive system. “Lo and behold, these sterile animals did not get… Read More ›
Public release date: 29-Apr-2010 •Clinical evaluation and magnetic resonance imaging (MRI) images show low blood levels of total vitamin D and certain active vitamin D byproducts are associated with increased disability, brain atrophy and brain lesion load in MS patients.
– They found that early-stage MS patients who had adequate levels of vitamin D had a 57% lower rate of new brain lesions, a 57% lower relapse rate, and a 25% lower yearly increase in lesion volume than those with… Read More ›
– shown to significantly reverse an MS-like disease in an animal – After 14 days, the EAE mice that had been treated with the MitoQ exhibited reduced inflammatory markers and increased neuronal activity in the spinal cord